Jay R. Luly

CEO

Board Member

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

Affiliation history

Recorded current and former roles; source labels appear when available.

Recorded roles and earnings-call appearances connecting this person to public companies.

ENTA

Current role

CEO, Board Member

2003-01-01–present

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year	Company	Role	Salary	Bonus	Stock awards	Option awards	Incentive	Other	Total
2025	Enanta Pharmaceuticals Inc (ENTA)	President and Chief Executive Officer	$803,300	—	$128,550	$1,223,975	$591,665	$22,058	$2,769,548
2024	Enanta Pharmaceuticals Inc (ENTA)	President and Chief Executive Officer	$779,875	—	$166,367	$1,297,481	$429,455	$22,098	$2,695,276
2023	Enanta Pharmaceuticals Inc (ENTA)	President and Chief Executive Officer	$755,375	—	$3,520,440	$3,084,399	$475,886	$20,598	$7,856,698
2022	Enanta Pharmaceuticals Inc (ENTA)	President and Chief Executive Officer	$725,050	—	$2,305,881	$3,739,269	$483,032	$19,424	$7,272,656
2021	Enanta Pharmaceuticals Inc (ENTA)	President and Chief Executive Officer	$693,188	—	$1,778,616	$2,283,872	$518,822	$19,211	$5,293,709
2020	Enanta Pharmaceuticals Inc (ENTA)	President and Chief Executive Officer	$667,063	—	$497,039	$3,598,848	$415,716	$19,171	$5,197,837
2019	Enanta Pharmaceuticals Inc (ENTA)	President and Chief Executive Officer	$641,825	—	$457,603	$3,027,598	$337,326	$19,151	$4,483,503
2018	Enanta Pharmaceuticals Inc (ENTA)	President and Chief Executive Officer	$611,178	—	$838,530	$2,684,490	$311,150	$18,851	$4,464,199
2017	Enanta Pharmaceuticals Inc (ENTA)	President and Chief Executive Officer	$581,203	—	$1,279,980	$2,055,720	$345,648	$18,551	$4,281,102

No earnings-call appearances or filed executive changes recorded yet.